NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) molecules are expressed on the cell surface, where they present peptides to T cells, which gives them a key role in the development of T-cell immune responses. MHC molecules come in two main variants: MHC Class I (MHC-I) and MHC Class II (MHC-II). MHC-I predominantly present peptides derived from intracellular proteins, whereas MHC-II predominantly presents peptides from extracellular proteins. In both cases, the binding between MHC and antigenic peptides is the most selective step in the antigen presentation pathway. Therefore, the prediction of peptide binding to MHC is a powerful utility to predict the possible specificity of a T-cell immune response. Commonly MHC binding prediction tools are trained on binding affinity or mass spectrometry-eluted ligands. Recent studies have however demonstrated how the integration of both data types can boost predictive performances. Inspired by this, we here present NetMHCpan-4.1 and NetMHCIIpan-4.0, two web servers created to predict binding between peptides and MHC-I and MHC-II, respectively. Both methods exploit tailored machine learning strategies to integrate different training data types, resulting in state-of-the-art performance and outperforming their competitors. The servers are available at http://www.cbs.dtu.dk/services/NetMHCpan-4.1/ and http://www.cbs.dtu.dk/services/NetMHCIIpan-4.0/.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among these tools, NetMHCpan stands out in predicting the binding affinity between peptides and MHC-I/II, respectively [139].”
From Single-cell sequencing to multi-omics: technologies and applications (2024) · cites this paper as [139]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jurtz, V., Paul, S., Andreatta, M., Marcatili, P., Peters, B., & Nielsen, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700893 · Cited by 1,470
Self-citationImproved methods for predicting peptide binding affinity to MHC class II molecules
Jensen, K. K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J. A., Yan, Z., Sette, A., Peters, B., & Nielsen, M. (2018) · Immunology · doi:10.1111/imm.12889 · Cited by 794
Self-citationAbelin, J. G., Keskin, D. B., Sarkizova, S., Hartigan, C. R., Zhang, W., Sidney, J., Stevens, J., Lane, W., Zhang, G. L., Eisenhaure, T. M., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.02.007 · Cited by 617
Nielsen, M., & Andreatta, M. (2016) · Genome Medicine · doi:10.1186/s13073-016-0288-x · Cited by 517
Self-citationSarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0322-9 · Cited by 499
Reynisson, B., Barra, C., Kaabinejadian, S., Hildebrand, W. H., Peters, B., & Nielsen, M. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00874 · Cited by 445
Self-citationMHCflurry: Open-Source Class I MHC Binding Affinity Prediction
O'Donnell, T. J., Rubinsteyn, A., Bonsack, M., Riemer, A. B., Laserson, U., & Hammerbacher, J. (2018) · Cell Systems · doi:10.1016/j.cels.2018.05.014 · Cited by 409
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Bulik-Sullivan, B., Busby, J., Palmer, C. D., Davis, M. J., Murphy, T., Clark, A., Busby, M., Duke, F., Yang, A., Young, L., et al. (2019) · Nature Biotechnology · doi:10.1038/nbt.4313 · Cited by 307
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Racle, J., Michaux, J., Rockinger, G. A., Arnaud, M., Bobisse, S., Chong, C., Guillaume, P., Coukos, G., Harari, A., Jandus, C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0289-6 · Cited by 289
Karosiene, E., Rasmussen, M., Blicher, T., Lund, O., Buus, S., & Nielsen, M. (2013) · Immunogenetics · doi:10.1007/s00251-013-0720-y · Cited by 272
Self-citation
Research works printed but not linked: 1
- O’Donnell T.J., Rubinsteyn A., Bonsack M., Riemer A.B., Laserson U., Hammerbacher J. 2020; MHCFlurry https://github.com/openvax/mhcflurry. 29960884
Cited by
Items 601–700 of 1,014
Computational methods and data resources for predicting tumor neoantigens
Zhao, X., Wei, L., & Zhang, X. (2025) · Briefings in Bioinformatics · doi:10.1093/bib/bbaf302 · Cited by 16
Timofeeva, A. M., Aulova, K. S., Mustaev, E. A., & Nevinsky, G. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188793 · Cited by 16
Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity
Kocher, K., Drost, F., Tesfaye, A. M., Moosmann, C., Schülein, C., Grotz, M., D’Ippolito, E., Graw, F., Spriewald, B. M., Busch, D. H., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.adu6730 · Cited by 16
Leddy, O. K., Ogongo, P., Huffaker, J., Gan, M., Milligan, R., Mahmud, S., Ni, H. M., Yuki, Y., Bobosha, K., Wassie, L., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adw9184 · Cited by 16
Nagaoka, K., Sun, C., Kobayashi, Y., Kanaseki, T., Tokita, S., Komatsu, T., Maejima, K., Futami, J., Nomura, S., Udaka, K., et al. (2021) · Cancers · doi:10.3390/cancers14010106 · Cited by 16
Basir, H. R. G., Majzoobi, M. M., Ebrahimi, S., Noroozbeygi, M., Hashemi, S. H., Keramat, F., Mamani, M., Eini, P., Alizadeh, S., Solgi, G., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.891816 · Cited by 16
Viral informatics: bioinformatics-based solution for managing viral infections
Kumar, S., Kumar, G. S., Maitra, S. S., Malý, P., Bharadwaj, S., Sharma, P., & Dwivedi, V. D. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac326 · Cited by 16
Kumar, A., Rathi, E., & Kini, S. G. (2022) · 3 Biotech · doi:10.1007/s13205-022-03286-0 · Cited by 16
Joshi, A., Akhtar, N., Sharma, N. R., Kaushik, V., & Borkotoky, S. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2191137 · Cited by 16
Hiu, J. J., Fung, J. K. Y., Tan, H. S., & Yap, M. K. K. (2023) · Scientific Reports · doi:10.1038/s41598-023-39222-2 · Cited by 16
Li, Y., Sackett, P. W., Nielsen, M., & Barra, C. (2023) · Bioinformatics Advances · doi:10.1093/bioadv/vbad151 · Cited by 16
Self-citationMasum, M. H. U., Ferdous, J., Lokman, S. M., & Siddiki, A. Z. (2023) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2023.101422 · Cited by 16
Martin, M. V., Aguilar-Rosas, S., Franke, K., Pieterse, M., van Langelaar, J., Schreurs, R., Bijlsma, M. F., Besselink, M. G., Köster, J., Timens, W., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-0158 · Cited by 16
Lehmann, A. A., Reche, P. A., Zhang, T., Suwansaard, M., & Lehmann, P. (2021) · Cells · doi:10.3390/cells10020248 · Cited by 16
Dudaniec, K., Westendorf, K., Nößner, E., & Uckert, W. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.283 · Cited by 16
Identification of a promiscuous conserved CTL epitope within the SARS-CoV-2 spike protein
Jiang, S., Wu, S., Zhao, G., He, Y., Guo, X., Zhang, Z., Hou, J., Ding, Y., Cheng, A., & Wang, B. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2043727 · Cited by 16
The Impact of Viral Mutations on Recognition by SARS-CoV-2 Specific T-CellsPreprint
de Silva, T. I., Liu, G., Lindsey, B. B., Dong, D., Shah, D. R., Mentzer, A. J., Angyal, A., Brown, R. L., Parker, M. D., Yin, Z., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3844713 · Cited by 16
Unraveling the glycosylated immunopeptidome with HLA-Glyco
Bedran, G., Polasky, D. A., Hsiao, Y., Yu, F., da Veiga Leprevost, F., Alfaro, J. A., Cieslik, M., & Nesvizhskii, A. I. (2023) · Nature Communications · doi:10.1038/s41467-023-39270-2 · Cited by 15
(2025) · doi:10.1093/protein/gzaf003 · Cited by 15
Yeh, C., Artz, O., Zhang, H., Karnoub, E.-R. R., Ntiamoah, P., Weipert, C. M., Walch, H. S., Harrold, E. C., Keane, F., Chalasani, S. B., et al. (2025) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-25-2566 · Cited by 15
Moustafa, R. I., Faraag, A. H. I., El‐Shenawy, R., Agwa, M. M., & Elsayed, H. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103661 · Cited by 15
SAPrIm, a semi-automated protocol for mid-throughput immunopeptidomics
Sian, T. C. C. L. K., Gonçalves, G., Steele, J. R., Shamekhi, T., Bramberger, L., Jin, D., Shahbazy, M., Purcell, A. W., Ramarathinam, S. H., Stoychev, S., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1107576 · Cited by 15
Ade, C. M., Sporn, M., Das, S., Yu, Z., Hanada, K., Qi, Y. A., Maity, T. K., Zhang, X., Guha, U., Andrésson, Þ., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007097 · Cited by 15
Clonal Neoantigen: Emerging “Mechanism-based” Biomarker of Immunotherapy Response
Nemunaitis, J. J., Stanbery, L., Willoughby, D., Bognar, E., Brun, S., Walter, A., Monk, B. J., Rocconi, R. P., Choucair, K., & Coleman, R. L. (2023) · Cancers · doi:10.3390/cancers15235616 · Cited by 15
Historical perspective and future directions: computational science in immuno-oncology
Ricker, C. A., Meli, K., & Allen, E. M. V. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008306 · Cited by 15
Structure-aware deep model for MHC-II peptide binding affinity prediction
Yu, Y., Zu, L., Jiang, J., Wu, Y., Wang, Y., Xu, M., & Liu, Q. (2024) · BMC Genomics · doi:10.1186/s12864-023-09900-6 · Cited by 15
DOTAD: A Database of Therapeutic Antibody Developability
Li, W., Lin, H., Huang, Z., Xie, S., Zhou, Y., Gong, R., Jiang, Q., Xiang, C., & Huang, J. H. (2024) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-024-00613-2 · Cited by 15
Yao, P., Gao, M., Hu, W., Wang, J., Wang, Y., Wang, Q., & Ji, J. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107209 · Cited by 15
Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation
Brunnberg, J., Barends, M., Frühschulz, S., Winter, C., Battin, C., de Wet, B., Cole, D. K., Steinberger, P., & Tampé, R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321600121 · Cited by 15
Ryan, N., Pratiwi, S. E., Mardhia, M., Ysrafil, Y., Liana, D. F., & Mahyarudin, M. (2024) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2024.0013 · Cited by 15
Epitopes screening and vaccine molecular design of PEDV S protein based on immunoinformatics
Li, S., Bai, X. T., & Wang, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-70579-0 · Cited by 15
CapHLA: a comprehensive tool to predict peptide presentation and binding to HLA class I and class II
Chang, Y., & Wu, L. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae595 · Cited by 15
Mamun, T. I., Ali, M. A., Hosen, M. N., Rahman, J., Islam, M. A., Akib, M. G., Zaman, K., Rahman, M. M., Hossain, F. M. A., Ibenmoussa, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1364129 · Cited by 15
Hu, Z., Wu, P., & Swanson, S. J. (2025) · The AAPS Journal · doi:10.1208/s12248-024-01003-8 · Cited by 15
Hamada, T., Ugai, T., Gurjao, C., Ugai, S., Zhang, X., Haruki, K., Takashima, Y., Akimoto, N., Lau, M. C., Matsuda, K., et al. (2025) · BMJ Oncology · doi:10.1136/bmjonc-2025-000787 · Cited by 15
Targeting infection-specific peptides in immunopeptidomics studies for vaccine target discovery
Leddy, O. K., Yuki, Y., Carrington, M. N., Bryson, B. D., & White, F. M. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20250444 · Cited by 15
Highly conserved Betacoronavirus sequences are broadly recognized by human T cells
Neto, T. A. P., Zmasek, C. M., Avalos, L., Sidney, J., Trevizani, R., Phillips, E. J., Mallal, S. A., Frazier, A., Tan, G. S., Scheuermann, R. H., et al. (2025) · Cell · doi:10.1016/j.cell.2025.07.015 · Cited by 15
Interpreting BERT architecture predictions for peptide presentation by MHC class I proteins
Gasser, H.-C., Bedran, G., Ren, B., Goodlett, D. R., Alfaro, J. A., & Rajan, A. (2021) · Edinburgh Research Explorer (University of Edinburgh) · doi:10.48550/arxiv.2111.07137 · Cited by 15
Cytotoxic T-Cell-Based Vaccine against SARS-CoV-2: A Hybrid Immunoinformatic Approach
Tîrziu, A., & Păunescu, V. (2022) · Vaccines · doi:10.3390/vaccines10020218 · Cited by 15
Specific human endogenous retroviruses predict metastatic potential in uveal melanoma
Bendall, M. L., Francis, J. H., Shoushtari, A. N., & Nixon, D. F. (2022) · JCI Insight · doi:10.1172/jci.insight.147172 · Cited by 15
Identification of Shared Neoantigens in BRCA1-Related Breast Cancer
Ruangapirom, L., Sutivijit, N., Teerapakpinyo, C., Mutirangura, A., & Doungkamchan, C. (2022) · Vaccines · doi:10.3390/vaccines10101597 · Cited by 15
Peng, S., Xing, D., Ferrall, L., Tsai, Y.-C., Hung, C., & Wu, T. ‐. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00864-5 · Cited by 15
Nandi, A., Manisha, Solanki, V., Tiwari, V., Sajjanar, B., Sankar, M., Saini, M., Shrivastava, S., Bhure, S. K., & Ghosh, S. (2023) · Vaccines · doi:10.3390/vaccines11040881 · Cited by 15
In-silico development of multi-epitope subunit vaccine against lymphatic filariasis
Singh, P. N. P., Shaikh, S., Gupta, S., & Gupta, R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2294838 · Cited by 15
Mubarak, A. S., Ameen, Z. S., Hassan, A. S., & Ozsahin, D. U. (2024) · Scientific Reports · doi:10.1038/s41598-024-59291-1 · Cited by 15
mRNA-Based Cancer Vaccines: Advancements and Prospects
Wu, L., Yi, W., Yao, S., Xie, S., Peng, R., Zhang, J., & Tan, W. (2024) · Nano Letters · doi:10.1021/acs.nanolett.4c03296 · Cited by 15
Bell, D. R., Domeniconi, G., Yang, C.-C., Zhou, R., Zhang, L., & Cong, G. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00870 · Cited by 15
Bekker, G., & Kamiya, N. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c07230 · Cited by 15
Pretti, M. A. M., Galvani, R. G. A., Scherer, N. D. M., Farias, A. S., & Boroni, M. (2022) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2022.105236 · Cited by 15
Charonis, S. A., James, L. M., & Georgopoulos, A. P. (2022) · Scientific Reports · doi:10.1038/s41598-022-11956-5 · Cited by 15
Ishwarlall, T. Z., Adeleke, V. T., Maharaj, L., Okpeku, M., Adeniyi, A. A., & Adeleke, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1023558 · Cited by 15
Structure modeling and specificity of peptide-MHC class I interactions using geometric deep learningPreprint
Aronson, A., Hochner, T., Cohen, T., & Schneidman‐Duhovny, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.15.520566 · Cited by 15
GraphMHC: Neoantigen prediction model applying the graph neural network to molecular structure
Jeong, H., Cho, Y.-R., Gim, J., Cha, S.-K., Kim, M., & Kang, D. R. (2024) · PLOS ONE · doi:10.1371/journal.pone.0291223 · Cited by 14
PANDORA v2.0: Benchmarking peptide-MHC II models and software improvements
Parizi, F. M., Marzella, D. F., Ramakrishnan, G., ‘t Hoen, P. A. C., Karimi-Jafari, M. H., & Xue, L. C. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285899 · Cited by 14
Ranking Peptide Binders by Affinity with AlphaFold**
Chang, L., & Perez, A. (2023) · Angewandte Chemie · doi:10.1002/ange.202213362 · Cited by 14
Yu, J., Wang, L., Kong, X., Cao, Y., Zhang, M., Sun, Z., Liu, Y., Wang, J., Shen, B., Bo, X., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.819583 · Cited by 14
Neoantigen identification: Technological advances and challenges
Pu, T., Peddle, A. M., Zhu, J., Tejpar, S., & Verbandt, S. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.06.005 · Cited by 14
Mao, Y., Xiao, X., Zhang, J., Mou, X., & Zhao, W. (2023) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2023.11.004 · Cited by 14
Utilizing Immunoinformatics for mRNA Vaccine Design against Influenza D Virus
Oladipo, E. K., Adeyemo, S. F., Akinboade, M. W., Akinleye, T. M., Siyanbola, K. F., Adeogun, P. A., Ogunfidodo, V. M., Adekunle, C. A., Elutade, O. A., Omoathebu, E. E., et al. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4020086 · Cited by 14
Rahman, S., Chiou, C.-C., Almutairi, M. M., Ajmal, A., Batool, S., Javed, B., Tanaka, T., Chen, C., Alouffi, A., & Ali, A. (2024) · Viruses · doi:10.3390/v16091408 · Cited by 14
Wang, B., Peng, X.-B., Li, J., Wang, Y.-R., Chen, L.-P., Wu, M.-H., Zhang, Y.-Y., Wang, W., Feng, D., Tang, S.-H., et al. (2024) · American Journal of Cancer Research · doi:10.62347/nvfb3780 · Cited by 14
Zhou, X., Qin, Y., Li, J., Fan, L., Zhang, S., Zhang, B., Wu, L., Gao, A., Yang, Y., Lv, X., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae905 · Cited by 14
Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae
Nahian, M., Shahab, M., Khan, M., Akash, S., Banu, T. A., Sarkar, M. M. H., Goswami, B., Chowdhury, S. F., Islam, M. A., Rus’d, A. A., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317216 · Cited by 14
Characterization of Tumor Antigens from Multi-omics Data: Computational Approaches and Resources
Wang, Y., Wengler, J., Fang, Y., Zhou, J., Ruan, H., Zhang, Z., & Han, L. (2025) · Genomics Proteomics & Bioinformatics · doi:10.1093/gpbjnl/qzaf001 · Cited by 14
Predicting specificity of TCR-pMHC interactions using machine-learning and biophysical models
Culka, M., Lounsbury, N., Thrift, W. J., Nerli, S., Wallace, A., Nikolényi, G., Orlova, D. Y., Mukhyala, K., & AlQuraishi, M. (2026) · Cell Systems · doi:10.1016/j.cels.2026.101700 · Cited by 14
Barua, A., Masum, M. H. U., & Mahdeen, A. A. (2025) · Bioinformatics and Biology Insights · doi:10.1177/11779322251331104 · Cited by 14
Li, S., Lv, H., Zhang, R., Li, J., Chen, Z., Yang, N., & Dai, S. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1575862 · Cited by 14
Gomase, V. S., Sharma, R., & Dhamane, S. P. (2025) · Protein and Peptide Letters · doi:10.2174/0109298665373152250625054723 · Cited by 14
Cao, C., Zhao, W., Guo, J., Wang, Z., Lü, A., & Liang, C. C. (2025) · The Innovation Medicine · doi:10.59717/j.xinn-med.2025.100154 · Cited by 14
Kowar, A., Becker, J. P., Pizzo, R. D., Tang, Z., Champagne, J., Wellach, K., Samimi, K., Galindo‐Albarrán, A., Körner, P.-R., Navarro, J. M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63405-2 · Cited by 14
The Yellow Fever Vaccine Journey: Milestones and Future Directions
Srivastava, S., Jayaswal, N., Gupta, P., Sridhar, S. B., Jaiswal, P., Tariq, M., Rao, G. S. N. K., Mohanty, A., Sah, S. K., Mehta, R., et al. (2026) · Vaccines · doi:10.3390/vaccines14010065 · Cited by 14
Yu, X., & Fu, K. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1808146 · Cited by 14
Symonds, P., Marcu, A., Cook, K., Metheringham, R. L., Durrant, L. G., & Brentville, V. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.764462 · Cited by 14
HLA Allele-Specific Quantitative Profiling of Type 1 Diabetic B Lymphocyte Immunopeptidome
Sudhir, P., Lin, T., & Zhang, Q. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00842 · Cited by 14
Is HLA type a possible cancer risk modifier in Lynch syndrome?
Ahadova, A., Witt, J., Haupt, S., Gallon, R., Hüneburg, R., Nattermann, J., ten Broeke, S. W., Bohaumilitzky, L., Hernandez‐Sanchez, A., Santibanez‐Koref, M., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34312 · Cited by 14
Wang, J., Weiß, T., Neidert, M. C., Toussaint, N. C., Naghavian, R., Moreno, C. S., Foege, M., Ojer, P. T., Medici, G., Jelčić, I., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1741 · Cited by 14
Antigenic molecular mimicry in viral-mediated protection from cancer: the HIV case
Manolio, C., Ragone, C., Cavalluzzo, B., Mauriello, A., Tornesello, M. L., Buonaguro, L., Megna, M., D’Alessio, G., Penta, R., Tagliamonte, M., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03681-4 · Cited by 14
Nguyen, T. L., Magdaleno, J. S. L., Shaikh, A. R., Choowongkomon, K., Li, V., Lee, Y. H., & Kim, H. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2153922 · Cited by 14
Usman, M., Ayub, A., Habib, S., Rana, M. S., Rehman, Z., Zohaib, A., Jamal, S. B., Jaiswal, A. K., Andrade, B. S., Azevedo, V., et al. (2023) · Vaccines · doi:10.3390/vaccines11040726 · Cited by 14
Deng, J., Zhou, X., Zhang, P., Cheng, W., Liu, M., & Tian, J. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad171 · Cited by 14
McShan, A. C., Flores‐Solis, D., Sun, Y., Garfinkle, S. E., Toor, J. S., Young, M. C., & Sgourakis, N. G. (2023) · Nature Communications · doi:10.1038/s41467-023-43654-9 · Cited by 15
Transfer learning improves pMHC kinetic stability and immunogenicity predictions
Fasoulis, R., Rigo, M., Antunes, D. A., Παλιούρας, Γ., & Kavraki, L. E. (2023) · ImmunoInformatics · doi:10.1016/j.immuno.2023.100030 · Cited by 14
Barajas, A., Amengual-Rigo, P., Pons-Grífols, A., Ortiz, R., Carmona, O. G., Urrea, V., de la Iglesia, N., Blanco-Heredia, J., Souza, C. A., Varela, I., et al. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04843-8 · Cited by 14
Yin, R., Melton, S., Huseby, E. S., Kardar, M., & Chakraborty, A. K. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2318599121 · Cited by 14
Kim, S. H., Lee, B. R., Kim, S., Kim, S., Kim, M.-S., Kim, J., Lee, I., Kim, H.-S., Nam, G., Kim, I., et al. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01259-2 · Cited by 14
Sun, Z., Zheng, X., Ji, F., Zhou, M., Su, X., Ren, K., & Li, L. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000071 · Cited by 14
Tran, N. H., Xu, J., & Li, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab493 · Cited by 14
Immunoinformatics approach of epitope prediction for SARS-CoV-2
Awad, N., Mohamed, R. H., Ghoneim, N. I., Elmehrath, A. O., & El‐Badri, N. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00344-1 · Cited by 14
Ianni, A. D., Barbero, L. M., Fraone, T., Cowan, K. J., & Sirtori, F. R. (2023) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2023.115500 · Cited by 14
Hermawan, A., Damai, F. I., Martin, L., Chrisdianto, M., Julianto, N. M., Pramanda, I. T., & Gustiananda, M. (2022) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-022-10467-1 · Cited by 13
García‐Mulero, S., Fornelino, R., Punta, M., Lise, S., Varela, M., del Carpio, L. P., Moreno, R., Costa-García, M., Rieder, D., Trajanoski, Z., et al. (2023) · OncoImmunology · doi:10.1080/2162402x.2023.2261278 · Cited by 13
MHCSeqNet2—improved peptide-class I MHC binding prediction for alleles with low data
Wongklaew, P., Sriswasdi, S., & Chuangsuwanich, E. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad780 · Cited by 13
Antonova, N. P., Vasina, D. V., Grigoriev, I. V., Laishevtsev, A. I., Капустин, А. В., Savinov, V. A., Vorobev, A. M., Aleshkin, A. V., Zackharova, A. A., Remizov, T. A., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107328 · Cited by 13
MicroEpitope: an atlas of immune epitopes derived from cancer microbiomes
Li, D., Cai, Y., Liu, K., Lv, D., Zeng, M., Wen, L., Lv, C., Guo, J., Xu, K., Ding, N., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae877 · Cited by 13
Genetic alteration of class I HLA in cutaneous T-cell lymphoma
Kwang, A. C., Durán, G. E., Fernandez‐Pol, S., Najidh, S., Li, S., Torres, A. N. B., Wang, E. B., Herrera, M. C., Bandali, T., Kurtz, D. M., et al. (2024) · Blood · doi:10.1182/blood.2024024817 · Cited by 13
Rapid parallel reconstruction and specificity screening of hundreds of T cell receptors
Afeyan, A. B., Wu, C. J., & Oliveira, G. (2024) · Nature Protocols · doi:10.1038/s41596-024-01061-4 · Cited by 13
Oladipo, E. K., Ogunniran, J. A., Akinpelu, O. S., Omole, T. O., Adeyemo, S. F., Irewolede, B. A., Iwalokun, B. A., Ajani, O. F., & Onyeaka, H. N. (2024) · BMC Immunology · doi:10.1186/s12865-024-00668-2 · Cited by 13
Khatrawi, E. M., Ali, S. L., Ali, S. Y., Abduldayeva, A. A., & Alhegaili, A. S. (2025) · Molecular Systems Design & Engineering · doi:10.1039/d5me00027k · Cited by 13
Huang, K., Lin, X.-J., Hu, J., Xia, T.-Y., Xu, F., Huang, J.-D., & Zhou, N. (2025) · Molecular Therapy Oncology · doi:10.1016/j.omton.2025.200986 · Cited by 13
der Vreken, A. V., Théry, F., Tu, C., Mwangi, K., Meulewaeter, S., Beck, L. D., Janssens, E., Veirman, K. D., Vanderkerken, K., Bruyne, E. D., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-010673 · Cited by 13
Metadata
- Authors
- Reynisson, B., Alvarez, B., Paul, S., Peters, B., & Nielsen, M.
- Affiliations
- Technical University of Denmark (DK)
- National University of General San Martín (AR)
- La Jolla Institute for Immunology (US)
- Corresponding author
- Nielsen, Morten
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-14
- Volume
- 48
- Issue
- W1
- Pages
- W449-W454
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC7319546
- OpenAlex
- W3024570138
- Cited by
- 2,361
- References
- 26
- Citations by year
- 2026: 493 · 2025: 550 · 2024: 459 · 2023: 345 · 2022: 250 · 2021: 216 · 2020: 47
- FWCI
- 69.61
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-sa)
- Funders
- National Institutes of Health (75N93019C00001)
- EIT Health (19638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- MHC-peptide binding prediction, MHC class I, MHC class II, antigen presentation, NetMHCpan, machine learning, web server, T cell response
- MeSH terms
- Machine Learning, Histocompatibility Antigens Class II, Ligands, Peptides, Software, Histocompatibility Antigens Class I, Antigen Presentation, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.